Dr William Davies, discusses updated international guidelines for the management of congenital ichthyoses, including X-linked ...

Dr Matthew Wheater examines liver-directed therapies for metastatic uveal melanoma and key findings from the pivotal FOCUS ...

E. coli is capable of turning plastic waste into paracetamol and could offer a new and sustainable production method, says ...

Genomic data and transformative technology, including the expansion of AI, wearables and the NHS App, are central to the NHS 10-year plan.

Senior doctors should get flexible working options and from age 60 should opt into on‐call only if they wish to, according to new guidance.

A recent publication by the British Thoracic Society offers the first long-term analysis of the UK Idiopathic Pulmonary Fibrosis Registry.

Insights from five case studies determining the benefits, challenges and potential of the drone transportation of medical supplies.

The cystic fibrosis medication ivacaftor is safe and effective in infants from four weeks of age, a phase 3 trial has found.

A low-carbon version of a triple combination pMDI inhaler indicated for adults with moderate-to-severe COPD has been approved by the MHRA.

Children with JIA are more likely to respond to methotrexate therapy if they have higher baseline expression of IFN-stimulated genes.

Waking critically ill Covid-19 patients for rehabilitation during prolonged ECMO therapy can improve their prognosis, a new study has found.

A new app providing information on blood clots and how to reduce the risk of developing one has been developed for at-risk patients.